Literature DB >> 32579470

Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice.

Klytaimnistra Kiouptsi1, Giulia Pontarollo1, Hristo Todorov2, Johannes Braun1, Sven Jäckel1,3, Thomas Koeck1,3,4, Franziska Bayer1, Cornelia Karwot1, Angelica Karpi5, Susanne Gerber2, Yvonne Jansen6, Philipp Wild1,3,4, Wolfram Ruf1,3,7, Andreas Daiber3,5, Emiel Van Der Vorst6,8,9,10, Christian Weber6,8, Yvonne Döring6,8,11, Christoph Reinhardt1,3.   

Abstract

The microbiota has been linked to the development of atherosclerosis, but the functional impact of these resident bacteria on the lesion size and cellular composition of atherosclerotic plaques in the aorta has never been experimentally addressed with the germ-free low-density lipoprotein receptor-deficient (Ldlr-/- ) mouse atherosclerosis model. Here, we report that 16 weeks of high-fat diet (HFD) feeding of hypercholesterolemic Ldlr-/- mice at germ-free (GF) housing conditions did not impact relative aortic root plaque size, macrophage content, and necrotic core area. Likewise, we did not find changes in the relative aortic arch lesion size. However, late atherosclerotic GF Ldlr-/- mice had altered inflammatory plasma protein markers and reduced smooth muscle cell content in their atherosclerotic root plaques relative to CONV-R Ldlr-/- mice. Neither absolute nor relative aortic root or aortic arch plaque size correlated with age. Our analyses on GF Ldlr-/- mice did not reveal a significant contribution of the microbiota in late aortic atherosclerosis.

Entities:  

Keywords:  Microbiota; age; aortic arch; aortic root; atherosclerosis; germ-free; inflammatory markers; lesion size; low-density lipoprotein receptor-deficient mouse; macrophages; smooth muscle cells

Year:  2020        PMID: 32579470      PMCID: PMC7524356          DOI: 10.1080/19490976.2020.1767463

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  50 in total

1.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Authors:  Zeneng Wang; Adam B Roberts; Jennifer A Buffa; Bruce S Levison; Weifei Zhu; Elin Org; Xiaodong Gu; Ying Huang; Maryam Zamanian-Daryoush; Miranda K Culley; Anthony J DiDonato; Xiaoming Fu; Jennie E Hazen; Daniel Krajcik; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

2.  Microbiota-Derived Trimethylamine.

Authors:  Klytaimnistra Kiouptsi; Wolfram Ruf; Christoph Reinhardt
Journal:  Circ Res       Date:  2018-10-26       Impact factor: 17.367

3.  Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling.

Authors:  Maria L Balmer; Christian M Schürch; Yasuyuki Saito; Markus B Geuking; Hai Li; Miguelangel Cuenca; Larisa V Kovtonyuk; Kathy D McCoy; Siegfried Hapfelmeier; Adrian F Ochsenbein; Markus G Manz; Emma Slack; Andrew J Macpherson
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

Review 4.  Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.

Authors:  Annika Wahlström; Sama I Sayin; Hanns-Ulrich Marschall; Fredrik Bäckhed
Journal:  Cell Metab       Date:  2016-06-16       Impact factor: 27.287

5.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

Authors:  S Ishibashi; M S Brown; J L Goldstein; R D Gerard; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Oral microbiota in patients with atherosclerosis.

Authors:  Frida Fåk; Valentina Tremaroli; Göran Bergström; Fredrik Bäckhed
Journal:  Atherosclerosis       Date:  2015-10-24       Impact factor: 5.162

7.  Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.

Authors:  Erika Assarsson; Martin Lundberg; Göran Holmquist; Johan Björkesten; Stine Bucht Thorsen; Daniel Ekman; Anna Eriksson; Emma Rennel Dickens; Sandra Ohlsson; Gabriella Edfeldt; Ann-Catrin Andersson; Patrik Lindstedt; Jan Stenvang; Mats Gullberg; Simon Fredriksson
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

8.  Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation.

Authors:  Siddhartha S Ghosh; Jinghua Bie; Jing Wang; Shobha Ghosh
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

9.  Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury.

Authors:  Kelly Wun; Betty R Theriault; Joseph F Pierre; Edmund B Chen; Vanessa A Leone; Katharine G Harris; Liqun Xiong; Qun Jiang; Melanie Spedale; Owen M Eskandari; Eugene B Chang; Karen J Ho
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

10.  The intestinal microbiota regulates host cholesterol homeostasis.

Authors:  Tiphaine Le Roy; Emelyne Lécuyer; Benoit Chassaing; Moez Rhimi; Marie Lhomme; Samira Boudebbouze; Farid Ichou; Júlia Haro Barceló; Thierry Huby; Maryse Guerin; Philippe Giral; Emmanuelle Maguin; Nathalie Kapel; Philippe Gérard; Karine Clément; Philippe Lesnik
Journal:  BMC Biol       Date:  2019-11-27       Impact factor: 7.431

View more
  8 in total

Review 1.  Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease.

Authors:  Nadja Paeslack; Maximilian Mimmler; Stefanie Becker; Zhenling Gao; My Phung Khuu; Amrit Mann; Frano Malinarich; Tommy Regen; Christoph Reinhardt
Journal:  Amino Acids       Date:  2022-04-22       Impact factor: 3.520

Review 2.  Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity.

Authors:  Valentina Rovella; Giuseppe Rodia; Francesca Di Daniele; Carmine Cardillo; Umberto Campia; Annalisa Noce; Eleonora Candi; David Della-Morte; Manfredi Tesauro
Journal:  Nutrients       Date:  2021-02-13       Impact factor: 5.717

Review 3.  Diet-gut microbiota interactions on cardiovascular disease.

Authors:  Xufei Zhang; Philippe Gérard
Journal:  Comput Struct Biotechnol J       Date:  2022-03-29       Impact factor: 7.271

4.  Circulating gut microbiota-related metabolites influence endothelium plaque lesion formation in ApoE knockout rats.

Authors:  Hsiao-Li Chuang; Chien-Chao Chiu; Ching Lo; Cheng-Chih Hsu; Ju-Yun Liu; Shao-Wen Hung; Shih-Chieh Tsai; Hsiang-Hsuan Sung; Chi-Kuang Leo Wang; Yen-Te Huang
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

Review 5.  Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease.

Authors:  Yingdong Lu; Yang Zhang; Xin Zhao; Chang Shang; Mi Xiang; Li Li; Xiangning Cui
Journal:  Front Cardiovasc Med       Date:  2022-08-11

6.  The Commensal Microbiota Enhances ADP-Triggered Integrin αIIbβ3 Activation and von Willebrand Factor-Mediated Platelet Deposition to Type I Collagen.

Authors:  Klytaimnistra Kiouptsi; Sven Jäckel; Eivor Wilms; Giulia Pontarollo; Jana Winterstein; Cornelia Karwot; Kathrin Groß; Kerstin Jurk; Christoph Reinhardt
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

Review 7.  The microbiome and rodent models of immune mediated diseases.

Authors:  Axel Kornerup Hansen; Camilla Hartmann Friis Hansen
Journal:  Mamm Genome       Date:  2021-04-01       Impact factor: 2.957

Review 8.  Recent Developments in Clinical Plasma Proteomics-Applied to Cardiovascular Research.

Authors:  Nicolai Bjødstrup Palstrøm; Rune Matthiesen; Lars Melholt Rasmussen; Hans Christian Beck
Journal:  Biomedicines       Date:  2022-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.